China���s Cancer Deaths Spur Merck Investment in Beijing Biotech

raise $100 million to $150 million, said John Oyler, its chief executive officer. BeiGene is part of a vanguard of health-care startups in the world���s most populous country. They are tapping government incentives that promote research and innovation,...